[HTML][HTML] The journey of antimalarial drugs against SARS-CoV-2
AA Sarhan, NA Ashour, AA Al‐Karmalawy - Informatics in medicine …, 2021 - Elsevier
The recent outbreak of coronavirus pandemic (COVID-19) introduced by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the global public …
respiratory syndrome coronavirus 2 (SARS-CoV-2) has greatly affected the global public …
Facts and myths: Efficacies of repurposing chloroquine and hydroxychloroquine for the treatment of COVID-19
AA Al-Bari - Current Drug Targets, 2020 - ingentaconnect.com
The emergence of coronavirus disease 2019 (COVID-19) is caused by the 2019 novel
coronavirus (2019-nCoV). The 2019-nCoV first broke out in Wuhan and subsequently …
coronavirus (2019-nCoV). The 2019-nCoV first broke out in Wuhan and subsequently …
[HTML][HTML] An update on antiviral therapy against SARS-CoV-2: how far have we come?
O Indari, S Jakhmola, E Manivannan… - Frontiers in …, 2021 - frontiersin.org
COVID-19 pandemic has spread worldwide at an exponential rate affecting millions of
people instantaneously. Currently, various drugs are under investigation to treat an …
people instantaneously. Currently, various drugs are under investigation to treat an …
[HTML][HTML] Repurposing chloroquine against multiple diseases with special attention to SARS-CoV-2 and associated toxicity
Chloroquine and its derivatives have been used since ages to treat malaria and have also
been approved by the FDA to treat autoimmune diseases. The drug employs pH-dependent …
been approved by the FDA to treat autoimmune diseases. The drug employs pH-dependent …
Repurposing drugs for COVID-19: Pharmacokinetics and pharmacogenomics of chloroquine and hydroxychloroquine
M Babayeva, Z Loewy - Pharmacogenomics and personalized …, 2020 - Taylor & Francis
Background A new coronavirus SARS-CoV-2 has been identified as the etiological agent of
the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 …
the severe acute respiratory syndrome, COVID-19, the source and cause of the 2019–20 …
A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials
VM Patil, S Singhal, N Masand - Life Sciences, 2020 - Elsevier
Recent global outbreak of the pandemic caused by coronavirus (COVID-19) emphasizes the
urgent need for novel antiviral therapeutics. It can be supplemented by utilization of efficient …
urgent need for novel antiviral therapeutics. It can be supplemented by utilization of efficient …
Multidrug treatment for COVID-19
M Ohe, K Furuya, H Goudarzi - Drug Discoveries & Therapeutics, 2021 - jstage.jst.go.jp
An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection,
which began in Wuhan, China in December 2019, has rapidly spread all over the world. The …
which began in Wuhan, China in December 2019, has rapidly spread all over the world. The …
In silico Potential of Approved Antimalarial Drugs for Repurposing Against COVID-19
Although the coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is wreaking havoc and resulting in …
respiratory syndrome coronavirus 2 (SARS-CoV-2) is wreaking havoc and resulting in …
An up-to-date overview of therapeutic agents for the treatment of COVID-19 disease
T Mulaw Belete - Clinical pharmacology: advances and …, 2020 - Taylor & Francis
Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has a great potential to
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …
overwhelm the world healthcare systems that may lead to high morbidity and mortality. It …
Chloroquine and hydroxychloroquine in the treatment of malaria and repurposing in treating COVID-19
Abstract Chloroquine (CQ) and Hydroxychloroquine (HCQ) have been commonly used for
the treatment and prevention of malaria, and the treatment of autoimmune diseases for …
the treatment and prevention of malaria, and the treatment of autoimmune diseases for …